Your browser doesn't support javascript.
loading
Towards consistency in pediatric brain tumor measurements: Challenges, solutions, and the role of artificial intelligence-based segmentation.
Familiar, Ariana M; Fathi Kazerooni, Anahita; Vossough, Arastoo; Ware, Jeffrey B; Bagheri, Sina; Khalili, Nastaran; Anderson, Hannah; Haldar, Debanjan; Storm, Phillip B; Resnick, Adam C; Kann, Benjamin H; Aboian, Mariam; Kline, Cassie; Weller, Michael; Huang, Raymond Y; Chang, Susan M; Fangusaro, Jason R; Hoffman, Lindsey M; Mueller, Sabine; Prados, Michael; Nabavizadeh, Ali.
Affiliation
  • Familiar AM; Center for Data-Driven Discovery in Biomedicine (D3b), Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Fathi Kazerooni A; Department of Neurosurgery, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Vossough A; Center for Data-Driven Discovery in Biomedicine (D3b), Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Ware JB; Department of Neurosurgery, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Bagheri S; AI2D Center for AI and Data Science for Integrated Diagnostics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Khalili N; Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Anderson H; Division of Radiology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Haldar D; Center for Data-Driven Discovery in Biomedicine (D3b), Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Storm PB; Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Resnick AC; Center for Data-Driven Discovery in Biomedicine (D3b), Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Kann BH; Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Aboian M; Center for Data-Driven Discovery in Biomedicine (D3b), Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Kline C; Department of Neurosurgery, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Weller M; Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Huang RY; Department of Neurosurgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
  • Chang SM; Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Fangusaro JR; Center for Data-Driven Discovery in Biomedicine (D3b), Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Hoffman LM; Department of Neurosurgery, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Mueller S; Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Prados M; Center for Data-Driven Discovery in Biomedicine (D3b), Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Nabavizadeh A; Department of Neurosurgery, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Neuro Oncol ; 26(9): 1557-1571, 2024 Sep 05.
Article in En | MEDLINE | ID: mdl-38769022
ABSTRACT
MR imaging is central to the assessment of tumor burden and changes over time in neuro-oncology. Several response assessment guidelines have been set forth by the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working groups in different tumor histologies; however, the visual delineation of tumor components using MRIs is not always straightforward, and complexities not currently addressed by these criteria can introduce inter- and intra-observer variability in manual assessments. Differentiation of non-enhancing tumors from peritumoral edema, mild enhancement from absence of enhancement, and various cystic components can be challenging; particularly given a lack of sufficient and uniform imaging protocols in clinical practice. Automated tumor segmentation with artificial intelligence (AI) may be able to provide more objective delineations, but rely on accurate and consistent training data created manually (ground truth). Herein, this paper reviews existing challenges and potential solutions to identifying and defining subregions of pediatric brain tumors (PBTs) that are not explicitly addressed by current guidelines. The goal is to assert the importance of defining and adopting criteria for addressing these challenges, as it will be critical to achieving standardized tumor measurements and reproducible response assessment in PBTs, ultimately leading to more precise outcome metrics and accurate comparisons among clinical studies.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Artificial Intelligence / Magnetic Resonance Imaging Limits: Child / Humans Language: En Journal: Neuro Oncol Journal subject: NEOPLASIAS / NEUROLOGIA Year: 2024 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Artificial Intelligence / Magnetic Resonance Imaging Limits: Child / Humans Language: En Journal: Neuro Oncol Journal subject: NEOPLASIAS / NEUROLOGIA Year: 2024 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido